Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levothyroxine for Proteinuria in CKD with Subclinical Hypothyroidism
NCT03898622Phase 3Completed
- Sponsor
- Hospital Civil de Guadalajara
- Start
- Oct 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypothyroidism comparing Group with levothyroxine with Group Placebo (2 arms). Primary endpoint: 24-hour Urine Proteinuria at 3 months. Started Oct 2018; status: completed.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on NCT03898622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03898622.